james Harrison

james Harrison


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 January 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
SJSamuel E. Jones
Samuel E. Jones
JLJacqueline M. Lane
Jacqueline M. Lane
AWAndrew R. Wood
Andrew R. Wood
VHVincent Van Hees
Vincent Van Hees
JTJessica Tyrrell
Jessica Tyrrell
MWMichael N. Weedon
Michael N. Weedon
Being a morning person is a behavioural indicator of a person’s underlying circadian rhythm. Using genome-wide data from 697,828 UK Biobank and 23andMe participants we increase the number of genetic loci associated with being a morning person from 24 to 351. Using data from 85,760 individuals with activity-monitor derived measures of sleep timing we find that the chronotype loci associate with sleep timing: the mean sleep timing of the 5% of individuals carrying the most morningness alleles is 25 min earlier than the 5% carrying the fewest. The loci are enriched for genes involved in circadian regulation, cAMP, glutamate and insulin signalling pathways, and those expressed in the retina, hindbrain, hypothalamus, and pituitary. Using Mendelian Randomisation, we show that being a morning person is causally associated with better mental health but does not affect BMI or risk of Type 2 diabetes. This study offers insights into circadian biology and its links to disease in humans.

5 April 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
SJSamuel E. Jones
Samuel E. Jones
VHVincent Van Hees
Vincent Van Hees
DMDiego R. Mazzotti
Diego R. Mazzotti
Pedro Marques-VidalPedro Marques-Vidal
Pedro Marques-Vidal
SSSéverine Sabia
Séverine Sabia
AWAndrew R. Wood
Andrew R. Wood
Sleep is an essential human function but its regulation is poorly understood. Using accelerometer data from 85,670 UK Biobank participants, we perform a genome-wide association study of 8 derived sleep traits representing sleep quality, quantity and timing, and validate our findings in 5,819 individuals. We identify 47 genetic associations at P < 5 × 10−8, of which 20 reach a stricter threshold of P < 8 × 10−10. These include 26 novel associations with measures of sleep quality and 10 with nocturnal sleep duration. The majority of identified variants associate with a single sleep trait, except for variants previously associated with restless legs syndrome. For sleep duration we identify a missense variant (p.Tyr727Cys) in PDE11A as the likely causal variant. As a group, sleep quality loci are enriched for serotonin processing genes. Although accelerometer-derived measures of sleep are imperfect and may be affected by restless legs syndrome, these findings provide new biological insights into sleep compared to previous efforts based on self-report sleep measures.

15 September 2023 in eClinicalMedicine
Verified
Journal Article
Open access
LJLeigh Jackson
Leigh Jackson
MWMichael N. Weedon
Michael N. Weedon
HGHarry D. Green
Harry D. Green
BMBethan Mallabar-Rimmer
Bethan Mallabar-Rimmer
JHjames Harrison
james Harrison
CWCaroline F. Wright
Caroline F. Wright
We sought to investigate how penetrance of familial cancer syndromes varies with family history using a population-based cohort. We analysed 454,712 UK Biobank participants with exome sequence and clinical data (data collected between March 2006 and June 2021). We identified participants with a self-reported family history of breast or colorectal cancer and a pathogenic/likely pathogenic variant in the major genes responsible for hereditary breast cancer or Lynch syndrome. We calculated survival to cancer diagnosis (controlled for sex, death, recruitment centre, screening and prophylactic surgery). Women with a pathogenic BRCA1 or BRCA2 variant had an increased risk of breast cancer that was higher in those with a first-degree family history (relative hazard 10.3 and 7.8, respectively) than those without (7.2 and 4.7). Penetrance to age 60 was also higher in those with a family history (44.7%, CI 32.2–59.3 and 24.1%, CI 17.5–32.6) versus those without (22.8%, CI 15.9–32.0 and 17.9%, CI 13.8–23.0). A similar pattern was seen in Lynch syndrome: individuals with a pathogenic MLH1, MSH2 or MSH6 variant had an increased risk of colorectal cancer that was significantly higher in those with a family history (relative hazard 35.6, 48.0 and 9.9) than those without (13.0, 15.4 and 7.2). Penetrance to age 60 was also higher for carriers of a pathogenic MLH1 or MSH2 variant in those with a family history (30.9%, CI 18.1–49.3 and 38.3%, CI 21.5–61.8) versus those without (20.5% CI 9.6–40.5 and 8.3% CI 2.1–30.4), but not for MSH6 (6.5% CI 2.7–15.1 with family history versus 8.3%, CI 5.1–13.2). Relative risk increases were also observed both within and across conditions. Individuals with pathogenic cancer syndrome variants may be at a less elevated risk of cancer in the absence of a first-degree family history, so in the context of results return, family history should be considered when counselling patients on the risks and benefits of potential follow-up care. The current work is supported by the 10.13039/501100000265 MRC (grant no MR/T00200X/1). The MRC had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

11 June 2020 in Scientific Reports
Verified
Journal Article
Open access
JHjames Harrison
james Harrison
DTDivya Sri Priyanka Tallapragada
Divya Sri Priyanka Tallapragada
ABAlma Baptist
Alma Baptist
SSSeth A. Sharp
Seth A. Sharp
SBSeema Bhaskar
Seema Bhaskar
RORichard A. Oram
Richard A. Oram
Type 1 diabetes (T1D) is a significant problem in Indians and misclassification of T1D and type 2 diabetes (T2D) is a particular problem in young adults in this population due to the high prevalence of early onset T2D at lower BMI. We have previously shown a genetic risk score (GRS) can be used to discriminate T1D from T2D in Europeans. We aimed to test the ability of a T1D GRS to discriminate T1D from T2D and controls in Indians. We studied subjects from Pune, India of Indo-European ancestry; T1D (n = 262 clinically defined, 200 autoantibody positive), T2D (n = 345) and controls (n = 324). We used the 9 SNP T1D GRS generated in Europeans and assessed its ability to discriminate T1D from T2D and controls in Indians. We compared Indians with Europeans from the Wellcome Trust Case Control Consortium study; T1D (n = 1963), T2D (n = 1924) and controls (n = 2938). The T1D GRS was discriminative of T1D from T2D in Indians but slightly less than in Europeans (ROC AUC 0.84 v 0.87, p < 0.0001). HLA SNPs contributed the majority of the discriminative power in Indians. A T1D GRS using SNPs defined in Europeans is discriminative of T1D from T2D and controls in Indians. As with Europeans, the T1D GRS may be useful for classifying diabetes in Indians.

6 January 2023 in Taxonomy
Verified
Journal Article
Open access
PDF file
JHjames Harrison
james Harrison
RHRana M. F. Hussain
Rana M. F. Hussain
AAAndrew Aspin
Andrew Aspin
MGMurray R. Grant
Murray R. Grant
JVJoana Vicente
Joana Vicente
DSDavid Studholme
David Studholme
The Gram-negative bacterial genus Xanthomonas includes numerous infra-specific taxa known as pathovars, which are defined primarily on host range and disease symptoms. With the advent of molecular sequence data, many pathovars have been transferred from X. campestris into other Xanthomonas species to better harmonise taxonomy and phylogeny. We performed whole-genome shotgun sequencing on pathotype strains of the following X. campestris pathovars: blepharidis, carissae, clerodendri, convolvuli, coriandri, daturae, euphorbiae, fici, heliotropii, ionidii, lawsoniae, mirabilis, obscurae, paulliniae, pennamericanum, spermacoces, uppalii, vernoniae, viegasii and zingibericola. These genomes showed more than 98% average nucleotide identity with the type-strain of X. euvesicatoria and less than 88% with the type-strain of X. campestris. We propose the transfer of these pathovars into X. euvesicatoria and present an emended species description for X. euvesicatoria.

20 November 2020 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
JFJames Fasham
James Fasham
JLJoseph S. Leslie
Joseph S. Leslie
JHjames Harrison
james Harrison
JDJames Deline
James Deline
KWKatie B. Williams
Katie B. Williams
EBEmma L Baple
Emma L Baple
Many studies have demonstrated the clinical utility and importance of epilepsy gene panel testing to confirm the specific aetiology of disease, enable appropriate therapeutic interventions, and inform accurate family counselling. Previously, SCN9A gene variants, in particular a c.1921A>T p.(Asn641Tyr) substitution, have been identified as a likely autosomal dominant cause of febrile seizures/febrile seizures plus and other monogenic seizure phenotypes indistinguishable from those associated with SCN1A, leading to inclusion of SCN9A on epilepsy gene testing panels. Here we present serendipitous findings of genetic studies that identify the SCN9A c.1921A>T p.(Asn641Tyr) variant at high frequency in the Amish community in the absence of such seizure phenotypes. Together with findings in UK Biobank these data refute an association of SCN9A with epilepsy, which has important clinical diagnostic implications.